消化管治療薬市場レポート：タイプ別、投与経路別、用途別、流通チャネル別、地域別、2025年～2033年

世界の消化管治療薬市場規模は2024年に485億米ドルに達しました。今後、IMARC Groupは、2033年には718億米ドルに達し、2025年～2033年の成長率（CAGR）は4.23％になると予測しています。

胃腸（GI）症候群は、消化管の臓器の機能に影響を及ぼす医学的疾患を指します。胃、膵臓、小腸、大腸、胆のう、肝臓に影響を及ぼし、通常、消化不良、胸やけ、便秘、腹部膨満感を特徴とします。一般的に使用される消化管治療薬には、制酸剤、下剤、止瀉剤、制吐剤、抗潰瘍剤などの処方薬や市販薬、内視鏡検査、X線検査、血液学的検査などがあります。これらの治療薬は、障害の発見や食物からの栄養吸収を助け、消化を改善し、消化器系の水流を調整し、胃酸を最小限に抑えます。

炎症性腸疾患（IBD）や潰瘍性大腸炎などのGI疾患の有病率の増加は、市場の成長を促進する主な要因の一つです。ライフスタイルの変化や不健康な食習慣により、世界中の患者の間で疾患再発の可能性が高まっています。さらに、このような病気にかかりやすい老年人口が増加していることも、市場成長の原動力となっています。この疾患の治療のための革新的なバイオシミラーや細胞療法の開発など、様々な技術的進歩が他の成長促進要因として作用しています。これらの生物製剤は静脈注射や皮下注射によって投与され、標的治療のために個別化されています。大衆の健康意識の高まり、広範な研究開発活動、特に新興経済諸国におけるヘルスケアインフラの大幅な改善など、その他の要因も市場をさらに牽引すると予想されます。

本レポートで扱う主な質問

• 世界の消化管治療薬市場はこれまでどのように推移し、今後どのように推移していくのか？
• COVID-19が世界の消化管治療薬市場に与えた影響は？
• 主要な地域市場とは？
• タイプ別の市場内訳は？
• 投与経路別の市場内訳は？
• 用途別の市場内訳は？
• 流通チャネル別の市場内訳は？
• 業界のバリューチェーンにおける様々な段階とは？
• 業界の主要な促進要因と課題は何か？
• 世界の消化管治療薬市場の構造と主要企業は？
• 業界における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の消化管治療薬市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：タイプ別

• ブランド
• ジェネリック

第7章 市場内訳：投与経路別

• 経口
• 静脈内
• その他

第8章 市場内訳：用途別

• 潰瘍性大腸炎
• クローン病
• 逆流性食道炎
• その他

第9章 市場内訳：流通チャネル別

• 病院薬局
• 小売薬局
• オンライン薬局

第10章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ

第11章 SWOT分析

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

第14章 価格分析

第15章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Abbott Laboratories
  • AbbVie Inc.
  • AstraZeneca Plc
  • Bausch Health Companies Inc.
  • Bayer Aktiengesellschaft
  • GlaxoSmithKline Plc
  • Janssen Biotech Inc.（Johnson & Johnson）
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Sanofi S.A.
  • Takeda Pharmaceuticals

List of Figures

• Figure 1: Global: Gastrointestinal Therapeutics Market: Major Drivers and Challenges
• Figure 2: Global: Gastrointestinal Therapeutics Market: Sales Value (in Billion USD), 2019-2024
• Figure 3: Global: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 4: Global: Gastrointestinal Therapeutics Market: Breakup by Type (in %), 2024
• Figure 5: Global: Gastrointestinal Therapeutics Market: Breakup by Route of Administration (in %), 2024
• Figure 6: Global: Gastrointestinal Therapeutics Market: Breakup by Application (in %), 2024
• Figure 7: Global: Gastrointestinal Therapeutics Market: Breakup by Distribution Channel (in %), 2024
• Figure 8: Global: Gastrointestinal Therapeutics Market: Breakup by Region (in %), 2024
• Figure 9: Global: Gastrointestinal Therapeutics (Branded) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 10: Global: Gastrointestinal Therapeutics (Branded) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 11: Global: Gastrointestinal Therapeutics (Generic) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 12: Global: Gastrointestinal Therapeutics (Generic) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 13: Global: Gastrointestinal Therapeutics (Oral) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 14: Global: Gastrointestinal Therapeutics (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 15: Global: Gastrointestinal Therapeutics (Intravenous) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 16: Global: Gastrointestinal Therapeutics (Intravenous) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 17: Global: Gastrointestinal Therapeutics (Others) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 18: Global: Gastrointestinal Therapeutics (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 19: Global: Gastrointestinal Therapeutics (Ulcerative Colitis) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 20: Global: Gastrointestinal Therapeutics (Ulcerative Colitis) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 21: Global: Gastrointestinal Therapeutics (Crohn's Disease) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 22: Global: Gastrointestinal Therapeutics (Crohn's Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 23: Global: Gastrointestinal Therapeutics (GERD) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 24: Global: Gastrointestinal Therapeutics (GERD) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 25: Global: Gastrointestinal Therapeutics (Others) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 26: Global: Gastrointestinal Therapeutics (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 27: Global: Gastrointestinal Therapeutics (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 28: Global: Gastrointestinal Therapeutics (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 29: Global: Gastrointestinal Therapeutics (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 30: Global: Gastrointestinal Therapeutics (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 31: Global: Gastrointestinal Therapeutics (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 32: Global: Gastrointestinal Therapeutics (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 33: North America: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 34: United States: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 35: United States: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 36: Canada: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 37: Canada: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 38: North America: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 39: Asia-Pacific: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 40: China: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 41: China: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 42: Japan: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 43: Japan: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 44: India: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 45: India: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 46: South Korea: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 47: South Korea: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 48: Australia: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 49: Australia: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 50: Indonesia: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 51: Indonesia: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 52: Others: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 53: Others: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 54: Asia-Pacific: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 55: Europe: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 56: Germany: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 57: Germany: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 58: France: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 59: France: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 60: United Kingdom: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 61: United Kingdom: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 62: Italy: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 63: Italy: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 64: Spain: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 65: Spain: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 66: Russia: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 67: Russia: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 68: Others: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 69: Others: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 70: Europe: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 71: Latin America: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 72: Brazil: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 73: Brazil: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 74: Mexico: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 75: Mexico: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 76: Others: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 77: Others: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 78: Latin America: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 79: Middle East and Africa: Gastrointestinal Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 80: Middle East and Africa: Gastrointestinal Therapeutics Market: Breakup by Country (in %), 2024
• Figure 81: Middle East and Africa: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 82: Global: Gastrointestinal Therapeutics Industry: SWOT Analysis
• Figure 83: Global: Gastrointestinal Therapeutics Industry: Value Chain Analysis
• Figure 84: Global: Gastrointestinal Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Gastrointestinal Therapeutics Market: Key Industry Highlights, 2024 and 2033
• Table 2: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Type (in Million USD), 2025-2033
• Table 3: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
• Table 4: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Application (in Million USD), 2025-2033
• Table 5: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
• Table 6: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Region (in Million USD), 2025-2033
• Table 7: Global: Gastrointestinal Therapeutics Market: Competitive Structure
• Table 8: Global: Gastrointestinal Therapeutics Market: Key Players

The global gastrointestinal therapeutics market size reached USD 48.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 71.8 Billion by 2033, exhibiting a growth rate (CAGR) of 4.23% during 2025-2033.

Gastrointestinal (GI) syndrome refers to a medical ailment that affects the functioning of organs in the digestive tract. It impacts the stomach, pancreas, small and large intestines, gall bladder and liver and is usually characterized by indigestion, heartburn, constipation and bloating. Some of the commonly used GI therapeutics include prescription and over-the-counter (OTC) drugs, such as antacids, laxatives, antidiarrheal agents, antiemetics, antiulcer agents, and endoscopic and radiological procedures and hematological tests. These therapeutics assist in the detection of the disorder and absorbing nutrients from the food to improve digestion, regulate water flow in the GI system and minimize gastric acidity.

The increasing prevalence of GI diseases, such as inflammatory bowel disease (IBD) and ulcerative colitis, is one of the key factors driving the growth of the market. Due to changing lifestyle patterns and unhealthy dietary habits, there is an increased probability of disease recurrence among patients across the globe. Furthermore, the rising geriatric population, which is more susceptible to such ailments, is also driving the market growth. Various technological advancements, such as the development of innovative biosimilars and cellular therapies for the treatment of the disorder, are acting as other growth-inducing factors. These biologics are administered through intravenous and subcutaneous injections and are personalized for targeted treatments. Other factors, including rising health consciousness among the masses, extensive research and development (R&D) activities and significant improvements in the healthcare infrastructure, especially in developing economies, are anticipated to drive the market further.

Key Market Segmentation:

Breakup by Type:

• Branded
• Generic

Breakup by Route of Administration:

• Oral
• Intravenous
• Others

Breakup by Application:

• Ulcerative Colitis
• Crohn's Disease
• GERD
• Others

Breakup by Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Bausch Health Companies Inc., Bayer Aktiengesellschaft, GlaxoSmithKline Plc, Janssen Biotech Inc. (Johnson & Johnson), Novo Nordisk A/S, Pfizer Inc., Sanofi S.A. and Takeda Pharmaceuticals.

Key Questions Answered in This Report:

• How has the global gastrointestinal therapeutics market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global gastrointestinal therapeutics market?
• What are the key regional markets?
• What is the breakup of the market based on the type?
• What is the breakup of the market based on the route of administration?
• What is the breakup of the market based on the application?
• What is the breakup of the market based on the distribution channel?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global gastrointestinal therapeutics market and who are the key players?
• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Gastrointestinal Therapeutics Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Branded
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Generic
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Route of Administration

• 7.1 Oral
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Intravenous
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Others
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Application

• 8.1 Ulcerative Colitis
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Crohn's Disease
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 GERD
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Distribution Channel

• 9.1 Hospital Pharmacies
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Retail Pharmacies
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Online Pharmacies
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Abbott Laboratories
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 Financials
    • 15.3.1.4 SWOT Analysis
  • 15.3.2 AbbVie Inc.
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
    • 15.3.2.3 Financials
    • 15.3.2.4 SWOT Analysis
  • 15.3.3 AstraZeneca Plc
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
    • 15.3.3.3 Financials
    • 15.3.3.4 SWOT Analysis
  • 15.3.4 Bausch Health Companies Inc.
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
    • 15.3.4.3 Financials
    • 15.3.4.4 SWOT Analysis
  • 15.3.5 Bayer Aktiengesellschaft
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
    • 15.3.5.3 Financials
    • 15.3.5.4 SWOT Analysis
  • 15.3.6 GlaxoSmithKline Plc
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
    • 15.3.6.3 Financials
    • 15.3.6.4 SWOT Analysis
  • 15.3.7 Janssen Biotech Inc. (Johnson & Johnson)
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
  • 15.3.8 Novo Nordisk A/S
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
    • 15.3.8.3 Financials
    • 15.3.8.4 SWOT Analysis
  • 15.3.9 Pfizer Inc.
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 Financials
    • 15.3.9.4 SWOT Analysis
  • 15.3.10 Sanofi S.A.
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
    • 15.3.10.3 Financials
    • 15.3.10.4 SWOT Analysis
  • 15.3.11 Takeda Pharmaceuticals
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio
    • 15.3.11.3 Financials
    • 15.3.11.4 SWOT Analysis